This inventor holds 1 USPTO granted patent. Top assignee: Biomarin Pharmaceutical Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Debra Lounsbury: Innovator in Therapeutic Solutions
Introduction
Debra Lounsbury is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for genetic disorders. Her work focuses on enhancing the treatment options available for adolescents suffering from phenylketonuria (PKU).
Latest Patents
Debra holds a patent for "Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating adolescent subjects." This patent involves phenylalanine ammonia-lyase (PAL) variants that exhibit greater phenylalanine-converting activity and reduced immunogenicity compared to wild-type PAL. These innovations are aimed at providing therapeutic benefits for adolescent subjects diagnosed with PKU.
Career Highlights
Debra Lounsbury has established herself as a key figure in the biotechnology sector. She is currently associated with BioMarin Pharmaceutical Inc., where she continues to work on groundbreaking research and development projects. Her expertise in enzyme therapy has positioned her as a leader in the quest for effective treatments for metabolic disorders.
Collaborations
Due to space constraints, the details of her collaborations will not be included.
Conclusion
Debra Lounsbury's innovative work in the field of biotechnology exemplifies her commitment to improving the lives of individuals with genetic disorders. Her contributions, particularly in the area of PKU treatment, highlight the importance of continued research and development in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile